Clinical evaluation of Siddha drug Sanmuga mezhugu in low back ache (sciatica).

Phase 2

Not yet recruiting

• Conditions: Sciatica,

• Registration Number: CTRI/2019/08/020779
• Lead Sponsor: Government Siddha medical college

Brief Summary

This is a Non randomized open clinical trail to study the safety and efficacy of Siddha drug Sanmuga mezhugu. The drug is given 100mg twice a day for 35 days with intermittent 7 days gap. Clinical trail is conducted after conducting Pre clinical toxicity study. The trail drug Sanmuga mezhugu is mentioned in Anuboga vaithya navaneetham part 7. During the trail all the study related data will be recorded and documented. After the completion of trail all the data will be analysed statistically.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2019-08-16
• Study Start: 2019-08-21

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Patients having pain in the low back or leg Burning or tingling sensation present in the posterior and lateral aspect of the leg Weakness, numbness and difficulty in moving the leg or foot A constant pain on one side of the back A positive SLR test.

Exclusion Criteria

Fracture of vertebrae Dislocation of vertebrae Deformities and congenital defects Known case of tuberculosis of spine Known case of neoplasm of spine Pregnancy and lactating women Multiple myeloma Patients of age below 25 above 60 years.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome of treatment is mainly assessed by reduction in clinical symptoms measured by using Roland-Morris disability scale	35 days with intermittent 7 days gap

Secondary Outcome Measures

Name	Time	Method
Secondary outcome of treatment is assessed by comparing the safety parameters before and after treatment	35 days with intermittent 7 days gap

Trial Locations

Locations (1)

Aringar Anna Government Hospital of Indian Medicine; 🇮🇳 Chennai, TAMIL NADU, India

Aringar Anna Government Hospital of Indian Medicine

🇮🇳Chennai, TAMIL NADU, India

Dr SUSHMITHA S

Principal investigator

8807012499

sushmithasrini9194@gmail.com